Table 3.
General characteristics | OR | 95% CI | p-value | |
---|---|---|---|---|
Lower | Upper | |||
Total | ||||
Sex (Female) | 0.761 | 0.624 | 0.928 | 0.007* |
Age (> 60 years) | 3.367 | 2.643 | 4.289 | < 0.001* |
Hypertension | 1.231 | 0.983 | 1.541 | 0.070 |
Diabetes | 1.195 | 0.928 | 1.540 | 0.168 |
Dyslipidemia | 1.610 | 1.291 | 2.008 | < 0.001* |
Stroke | 1.278 | 0.833 | 1.961 | 0.261 |
MDD | 1.466 | 1.026 | 2.097 | 0.036* |
COVID-19 pandemic | 1.600 | 1.318 | 1.943 | < 0.001* |
Aerobic physical activity | 1.076 | 0.880 | 1.315 | 0.477 |
Income | 0.572 | |||
Lower | 1 (ref) | |||
Middle-lower | 0.814 | 0.603 | 1.098 | 0.178 |
Middle-upper | 0.940 | 0.709 | 1.246 | 0.665 |
Upper | 0.933 | 0.702 | 1.240 | 0.633 |
Pre-COVID-19 | ||||
Sex (female) | 0.837 | 0.634 | 1.105 | 0.209 |
Age (> 60 years) | 3.160 | 2.287 | 4.367 | < 0.001* |
Hypertension | 1.128 | 0.822 | 1.546 | 0.456 |
Diabetes | 1.398 | 0.986 | 1.982 | 0.060 |
Dyslipidemia | 1.837 | 1.350 | 2.500 | < 0.001* |
Stroke | 1.472 | 0.839 | 2.583 | 0.178 |
MDD | 1.468 | 0.892 | 2.415 | 0.131 |
Aerobic physical activity | 1.217 | 0.921 | 1.608 | 0.167 |
Income | ||||
Lower | 0.221 | |||
Middle-lower | 1.023 | 0.678 | 1.545 | 0.913 |
Middle-upper | 1.263 | 0.852 | 1.874 | 0.245 |
Upper | 1.412 | 0.960 | 2.078 | 0.080 |
Post-COVID-19 | ||||
Sex (female) | 0.670 | 0.505 | 0.889 | 0.005* |
Age (> 60 years) | 3.215 | 2.309 | 4.476 | < 0.001* |
Hypertension | 1.325 | 0.963 | 1.822 | 0.084 |
Diabetes | 1.038 | 0.717 | 1.504 | 0.842 |
Dyslipidemia | 1.397 | 1.019 | 1.915 | 0.038* |
Stroke | 1.099 | 0.568 | 2.124 | 0.780 |
MDD | 1.517 | 0.908 | 2.534 | 0.112 |
Aerobic physical activity | 0.949 | 0.709 | 1.269 | 0.722 |
Income | 0.006* | |||
Lower | 1 (ref) | |||
Middle-lower | 2.115 | 1.366 | 3.275 | 0.001* |
Middle-upper | 1.960 | 1.260 | 3.050 | 0.003* |
Upper | 1.663 | 1.052 | 2.629 | 0.030* |
MDD Major depressive disorder. *p <0.05